QQQ   413.98 (-2.23%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
QQQ   413.98 (-2.23%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
QQQ   413.98 (-2.23%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)
QQQ   413.98 (-2.23%)
AAPL   164.93 (-1.26%)
MSFT   399.46 (-1.19%)
META   480.21 (-4.30%)
GOOGL   153.68 (-1.49%)
AMZN   173.91 (-2.96%)
TSLA   147.04 (-1.93%)
NVDA   771.66 (-8.86%)
AMD   145.95 (-5.89%)
NIO   3.81 (-4.75%)
BABA   69.04 (+0.23%)
T   16.51 (+1.10%)
F   12.08 (+0.17%)
MU   106.25 (-5.07%)
GE   148.23 (-3.08%)
CGC   7.96 (+1.66%)
DIS   112.17 (-0.23%)
AMC   3.18 (+8.90%)
PFE   25.93 (+2.13%)
PYPL   61.76 (-0.55%)
XOM   119.81 (+1.09%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ACEVU
ACE Convergence Acquisition
$9.77
-0.1%
$9.77
$9.27
$10.80
N/AN/A2,197 shs800 shs
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
$10.36
-0.2%
$10.36
$8.14
$11.35
N/AN/A4,697 shs400 shs
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
$0.02
$0.02
$0.02
$11.20
N/AN/A1,795 shsN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
$10.14
-7.7%
$10.14
$8.73
$11.11
N/AN/A4,444 shs1,300 shs
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
$24.97
+0.2%
$25.04
$23.86
$25.49
N/AN/A2,971 shs468 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ACEVU
ACE Convergence Acquisition
0.00%0.00%0.00%0.00%0.00%
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
0.00%0.00%0.00%0.00%0.00%
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
0.00%0.00%0.00%0.00%0.00%
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
0.00%0.00%0.00%0.00%0.00%
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
+0.24%+0.20%+0.44%-0.12%+1.92%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/AN/AN/AN/A
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/A
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
N/AN/AN/AN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
N/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/AN/A
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/AN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
N/AN/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ACEVU
ACE Convergence Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/A0.00N/AN/AN/AN/AN/A
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/A0.00N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ACEVU
ACE Convergence Acquisition
N/AN/AN/AN/AN/A
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
N/AN/AN/AN/AN/A
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
N/AN/AN/AN/AN/A
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
N/AN/AN/AN/AN/A
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
N/AN/AN/AN/AN/A

Ownership

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
ACEVU
ACE Convergence Acquisition
4N/AN/ANot Optionable
Ackrell SPAC Partners I Co. stock logo
ACKIU
Ackrell SPAC Partners I
2,020N/AN/ANot Optionable
Adara Acquisition Corp. stock logo
ADRAU
Adara Acquisition
147,000N/AN/ANot Optionable
Biotech Acquisition stock logo
BIOTU
Biotech Acquisition
4N/AN/ANot Optionable
Sachem Capital Corp. 7.125% Not stock logo
SCCB
Sachem Capital Corp. 7.125% Not
34N/AN/ANot Optionable

BIOTU, SCCB, ACEVU, ACKIU, and ADRAU Headlines

Media Sentiment Over Time

Company Descriptions

ACE Convergence Acquisition

OTCMKTS:ACEVU
ACE Convergence Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on businesses in the IT infrastructure software and semiconductor sectors. ACE Convergence Acquisition Corp. was incorporated in 2020 and is based in Wilmington, Delaware.
Ackrell SPAC Partners I logo

Ackrell SPAC Partners I

OTCMKTS:ACKIU
Ackrell SPAC Partners I Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on alcoholic and non-alcoholic beverage and wellness sectors. Ackrell SPAC Partners I Co. was founded in 2018 and is Claymont, Delaware.
Adara Acquisition logo

Adara Acquisition

OTCMKTS:ADRAU
Adara Acquisition Corp. was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any industry, it currently intends to concentrate its search for a target business operating in the consumer products and related industries.
Biotech Acquisition logo

Biotech Acquisition

OTCMKTS:BIOTU
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Sachem Capital Corp. 7.125% Not logo

Sachem Capital Corp. 7.125% Not

OTCMKTS:SCCB
since 2010, sachem capital has been financing opportunistic real estate transactions in the new england area. sachem capital provides quick, short-term bridge capital for real estate investors, builders or developers who need immediate funding or to solve an immediate problem. our creative real estate financing solutions are developed exclusively for those seeking alternatives to conventional bank loans. the executive team has extensive experience in real estate acquisitions, investments, management and development. our hands-on managers have the expertise to quickly assess complex opportunities and non-conventional situations to deliver a closing product that is efficient and opportunistic to our borrowers, and profitable to our shareholders. sachem capital was listed on the nyse on february 10, 2017. the company was designed to address the constant volatility and instability in today's financial markets. we are exited to share with you this extraordinary opportunity to seize favorabl